Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erythropoietin in low birth weight premature infants
IRCT20160511027853N2Phase 4Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Apr 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of erythropoietin in preterm birth and low birth weight (LBW) (2 arms), sponsored by Qazvin University of Medical Sciences. Primary endpoints: Improved neonatal anthropometric criteria, Decreased neonatal edema and 4 more. Started Apr 2020; status: completed.
02
Drugs
erythropoietin
03
Conditions
preterm birthlow birth weight (LBW)
Beyond the preview
Go deeper on IRCT20160511027853N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20160511027853N2.